CVS Health stock gains 1.48 percent as analysts stay positive

Published on 10/04/2026 at 09:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVS Health stock carries a USD 107.24 consensus target from 23 analysts. Second-quarter revenue reached USD 106.1 billion, up 7.3 percent year over year.

Schwarzweiß-Reportagefoto eines Apothekers beim Befüllen von Rezeptmedikamenten an der Theke — CVS Health Corp. dokumentiert Schwarzweiß-Reportage eines Apothekers bei der Rezeptabgabe, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock (ISIN US1266501006) closed at USD 86.46 on the NYSE on October 2, 2026, gaining 1.48 percent from the previous session. The latest analyst signal came from Cantor Fitzgerald, which reiterated an Overweight rating and a USD 110.00 price target on October 1, 2026, according to Investing.com.

Analysts see further upside

The consensus picture remains constructive. According to MarketBeat on October 4, 2026, 22 of 23 analysts carried Buy ratings, one held a Hold rating, and the average twelve-month target was USD 107.24.

That target stands USD 20.78 above the October 2 closing price, equivalent to 24.0 percent above it. The latest price also remained below the NYSE 52-week high of USD 110.68 while standing above the 52-week low of USD 69.51.

Second-quarter figures reset expectations

CVS Health reported second-quarter 2026 revenue of USD 106.1 billion, up 7.3 percent from the prior-year quarter, while adjusted EPS reached USD 2.58 versus USD 1.81 a year earlier. Ticker Scout identifies the report as filed on August 5, 2026 and also lists GAAP diluted EPS of USD 2.31 versus USD 0.80.

The same filing summary shows that CVS Health raised its full-year 2026 adjusted EPS guidance to USD 7.90-8.10 from USD 7.30-7.50. Operating cash flow guidance also increased to at least USD 11.5 billion from at least USD 9.5 billion, giving the earnings beat a broader cash-flow dimension.

CVS Health stock closes above USD 86

The October 2 session included a high of USD 87.15 and a low of USD 85.25, with volume of 10,446,777 shares. Market capitalization stood at USD 110.3 billion on the same date, placing the stock below its yearly peak despite the positive daily move.